Filgrastim biosimilar (EP2006): A review of 15 years’ post-approval evidence
Article in Critical Reviews in Oncology/Hematology (February 2024)
The most recent citing publications are shown below. View all 12 publications that cite this research output on Dimensions.
Article in Critical Reviews in Oncology/Hematology (February 2024)
Preprint in Research Square (December 2023)
Article in Cancer Investigation (March 2023)